Gabapentin Tablet, Film Coated
FDA Label NDC 65841-706

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Gabapentin (NDC 65841-706). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding spl medguide, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Spl Medguide

Manufactured by:

Cadila Heathcare Ltd.

India

Package Label.Principal Display Panel

NDC 65841-705-01 in bottle of 100 tablets

Gabapentin Tablets USP, 600 mg

Rx only

100 tablets

Gabapentin Tablets (F3828236 C43c 499c B065 71393e69ebc0 07)

Gabapentin Tablets (F3828236 C43c 499c B065 71393e69ebc0 07)

NDC 65841-706-01 in bottle of 100 tablets

Gabapentin Tablets USP, 800 mg

Rx only

100 tablets

Gabapentin Tablets (F3828236 C43c 499c B065 71393e69ebc0 08)

Gabapentin Tablets (F3828236 C43c 499c B065 71393e69ebc0 08)

* Please review the disclaimer below.